Abpro Holdings (ABPO) Accumulated Depreciation (2023 - 2025)
Abpro Holdings' (ABPO) quarterly Accumulated Depreciation came in at $2.7 million in Q2 2025, little changed on a QoQ basis from $2.7 million in Q1 2025.
Abpro Holdings (ABPO) Accumulated Depreciation (2023 - 2025) Analysis & Trends
Abpro Holdings (ABPO) has 3 years of Accumulated Depreciation data on file, last reported at $2.7 million in Q2 2025.
- Quarterly Accumulated Depreciation changed N/A year-over-year to $2.7 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2.7 million (changed N/A YoY) and the FY2024 annual result came in at $2.7 million, up 2.51% from the prior year.
- Accumulated Depreciation was little changed at $2.7 million in Q2 2025, from $2.7 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $2.7 million in Q1 2025 to a low of $2.6 million in Q4 2023.
- A 3-year average of $2.6 million and a median of $2.7 million in 2024 frame the typical range for Accumulated Depreciation.
- The widest YoY moves for Accumulated Depreciation: up 2.51% in 2024, down 2.51% in 2024.
- Tracing ABPO's Accumulated Depreciation over 3 years: stood at $2.6 million in 2023, then climbed by 2.51% to $2.7 million in 2024, then fell by 0.04% to $2.7 million in 2025.
- The last three Accumulated Depreciation figures came in at $2.7 million (Q2 2025), $2.7 million (Q1 2025), and $2.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 2.66 Mn |
| Dec 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 2.59 Mn |